Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Mather

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|February 24, 2007
Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabelingM Bashir-Uddin Surfraz, Robert King, Stephen J Mather, et al.
Journal of Medicinal Chemistry|July 14, 2009
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluationElisabeth von Guggenberg, Werner Sallegger, Anna Helbok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumorsMichael Gabriel, Clemens Decristoforo, Eveline Donnemiller, et al.
Nuclear Medicine Communications|February 4, 2010
The qualified person in radiopharmacyStephen J Mather, Paul Maltby, Bev Ellis, et al.
Dalton Transactions (Cambridge, England : 2003)|November 10, 2007
How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studiesRobert C King, M Bashir-Uddin Surfraz, Stefano C G Biagini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapyStephen J Mather, Andrew J McKenzie, Jane K Sosabowski, et al.
The Journal of Pathology|July 15, 2010
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6Antonio Saha, David Ellison, Gareth J Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptideJane K Sosabowski, Torkjel Matzow, Julie M Foster, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 1, 2010
Radiopeptide internalisation and externalization assays: cell viability and radioligand integritySyed Ali Raza Naqvi, Jane K Sosabowski, Saeed Ahamad Nagra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In VivoRobert King, M Bashir-Uddin Surfraz, Ciara Finucane, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|February 24, 2007
Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabelingM Bashir-Uddin Surfraz, Robert King, Stephen J Mather, et al.
Journal of Medicinal Chemistry|July 14, 2009
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluationElisabeth von Guggenberg, Werner Sallegger, Anna Helbok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumorsMichael Gabriel, Clemens Decristoforo, Eveline Donnemiller, et al.
Nuclear Medicine Communications|February 4, 2010
The qualified person in radiopharmacyStephen J Mather, Paul Maltby, Bev Ellis, et al.
Dalton Transactions (Cambridge, England : 2003)|November 10, 2007
How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studiesRobert C King, M Bashir-Uddin Surfraz, Stefano C G Biagini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapyStephen J Mather, Andrew J McKenzie, Jane K Sosabowski, et al.
The Journal of Pathology|July 15, 2010
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6Antonio Saha, David Ellison, Gareth J Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptideJane K Sosabowski, Torkjel Matzow, Julie M Foster, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 1, 2010
Radiopeptide internalisation and externalization assays: cell viability and radioligand integritySyed Ali Raza Naqvi, Jane K Sosabowski, Saeed Ahamad Nagra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In VivoRobert King, M Bashir-Uddin Surfraz, Ciara Finucane, et al.
Pageof 6